SCHD ETF at $33 Is the Best-Performing Dividend ETF of the Year and the Most Exposed to a Hiking Fed

The Schwab U.S. Dividend Equity ETF traded at $33.05 at 1:51 p.m. ET on Tuesday, down $0.17 or 0.50% on the session, with a net asset value of $33.20 at Monday's close and a bid-ask midpoint at the same level. The fund's premium to NAV was 0.04% and its 30-day median bid-ask spread was 0.03%, which is the liquidity profile of a $100 billion-plus product. Year to date SCHD is up roughly 20% on price and more on total return. It set a record high of $35.30 in the summer, 27% above where it started the year, and it has moved sideways for the past six weeks as the rally stalled. At $33.05 it is 6.4% below that high.

The performance is the best in its category and the best in years. SCHD's trailing-twelve-month total return is 26.24%, against 7.74% for JEPI, 19.94% for JEPQ, and 14.37% for VYM. Its one-year total return through August 11 was 32.18%. Its five-year annualized return is 9.75% and its since-inception average annual return is 9.36%. A fund built to hold 100 boring dividend payers with a 0.06% expense ratio outperformed the covered-call complex, the broad high-yield index, and for most of the year the S&P 500 itself, which is flat at 7,681 after erasing its September gain.

The flows have turned. SCHD's net assets fell $3.44 billion over the past five days and $2.02 billion over the past month, against gains of $14.43 billion over three months, $10.72 billion over six months, and $38.15 billion over one year. The fund has taken in more than $61 billion over three years and $82 billion over five, which is the most successful asset-gathering run of any dividend ETF in history. The five-day outflow is the first meaningful reversal of that run, and it coincides with the 10-year Treasury yield reaching 5.264%, the highest since 2007, and a Federal Reserve that raised rates on September 16 for the first time in three years and is priced at 70% to do so again on October 28.

The thesis for this analysis: SCHD is a bond proxy, and bond proxies get sold when bonds yield more than they do. The fund's 3.2% trailing yield sits 200 basis points below a Treasury that pays 5.26% with no equity risk, which is the widest negative spread in the fund's fifteen-year history. The 2026 rally happened because the market expected cuts; the six-week stall happened because it got a hike. The $3.44 billion of outflows is the first evidence that income allocators are rotating from dividend equity into duration, and the question for the fourth quarter is whether SCHD's 11% annual dividend growth and quality screen can hold the price above $32 while the yield gap closes.

The Distribution: $0.2665 Paid September 28, $1.05 Over Twelve Months, 3.2% at $33, and the Dividend Growth That Justifies It

SCHD paid its third-quarter distribution of $0.2665 per share on September 28, with an ex-dividend date of September 23. Over the trailing twelve months the fund has paid $1.05 per share, which at $33.05 is a 3.17% to 3.23% yield depending on the calculation. The distribution is quarterly, paid in March, June, September and December, and the next ex-date is December 9. The fund's 30-day SEC yield has ranged between 3.4% and 4.0% through 2026 depending on price, and it sits toward the low end of that range now because the price has risen faster than the payout.

The yield is the number that has stopped working. At 3.2%, SCHD pays 200 basis points less than the 10-year Treasury at 5.264% and 240 basis points less than the 30-year at 5.589%. For most of the fund's history it paid more than the 10-year: in 2020 and 2021 the spread was positive by 200 to 300 basis points, in 2023 it was roughly flat, and in 2024 and 2025 it was modestly negative. A 200-basis-point negative spread is unprecedented for the product, and it is the reason the five-day outflow is $3.44 billion. An income investor comparing a 3.2% equity yield with equity volatility against a 5.26% risk-free yield with none is making a simple decision, and $3.44 billion of them made it last week.

The counter is growth. SCHD's dividend has compounded at roughly 11% annualized over ten years, which is the fastest of any large dividend ETF and the reason a 3.2% yield today becomes a 5.5% yield on cost in five years and 9.3% in ten. A Treasury at 5.26% pays 5.26% forever. The fund's index screens for five-year dividend growth rate as one of four factors, and the 100 holdings are selected in part because they have raised payouts consistently. The quarterly distribution of $0.2665 is up from $0.2488 in the third quarter of 2025 and $0.2545 in the second quarter of 2026, a 7% year-over-year increase that is running below the ten-year average but well above inflation.

The tax treatment is the other edge. SCHD's distributions are predominantly qualified dividends taxed at capital-gains rates, against JEPI's distributions, which are largely ordinary income from option premium. For a taxable investor in the top bracket, SCHD's 3.2% is worth roughly 2.6% after tax and JEPI's 7.88% is worth roughly 4.7%, which narrows the gap from 470 basis points to 210. Against a Treasury, whose interest is taxed as ordinary income at the federal level but exempt at the state level, SCHD's after-tax yield is competitive only in high-tax states. The yield math is against the fund this quarter. The growth math is for it over the decade.

The Index: 100 Stocks, Four Screens, Ten Years of Dividends, and a March Reconstitution That Cut Energy

SCHD tracks the Dow Jones U.S. Dividend 100 Index, which is what separates it from every other dividend ETF. The eligible universe is U.S. stocks that have paid dividends for at least 10 consecutive years, with a minimum float-adjusted market capitalization of $500 million and minimum liquidity requirements, excluding REITs. From that universe the index ranks the highest-yielding stocks on a composite score built from four fundamental factors: cash flow to total debt, return on equity, dividend yield, and five-year dividend growth rate. The top 100 on the composite are selected and weighted by market capitalization, with individual positions capped at 4% and sectors at 25%. The index is rebalanced quarterly and fully reconstituted once a year in March.

The quality screen is the reason the fund holds Merck at 4.78%, Amgen at 4.72% and Verizon in its top ten rather than the highest-yielding names in the market. Cash flow to total debt filters out leveraged balance sheets; return on equity filters out capital-destroying businesses; the dividend-growth factor filters out companies that pay high yields because their stock has collapsed. The result is a portfolio that yields less than the broad high-dividend universe and has outperformed it on total return over most windows, because the companies it holds are the ones that keep raising the payout.

The March 2026 reconstitution changed the character of the fund. It added two healthcare stocks to the top ten, a "healthy dose" of high-yielding pharmaceutical and biotech names, and cut its exposure to energy stocks despite the sector having received a war-fueled boost from oil prices that were already above $90. That rotation is why SCHD did not participate in the September energy rally when Brent touched $108, and it is why the fund's top holdings are now healthcare, consumer staples and telecom rather than the integrated oils that carried it in 2022. The turnover rate at the reconstitution was nearly 42%, which is high for an index fund and is the cost of a rules-based screen that re-ranks the universe annually.

The methodology is also a constraint. A 4% position cap means the fund cannot ride a single winner the way a market-cap index can; a 25% sector cap means it cannot overweight the sector that is working; and the 10-year dividend requirement means it will never own the technology companies that initiated dividends in 2024 and 2025 until 2034. SCHD is structurally underweight technology, structurally overweight healthcare and staples, and structurally a value fund. That is exactly what made it work in 2026, when the AI trade cracked in September and defensives caught a bid. It is also what makes it a bond proxy: the companies it holds are the ones whose valuations are most sensitive to the discount rate.

The Rate Shock: 5.264% on the Ten-Year, a Fed That Hiked, and the End of the Cut-Driven Rally

SCHD's 2026 rally was a rates trade. The fund entered the year at $27.32 with the 10-year Treasury near 4.10% and the market expecting the Fed to continue cutting from the 3.50% to 3.75% range it reached in December 2025. Every 25 basis points of expected cuts is worth roughly 3% to 4% on a dividend fund whose holdings trade at 17 times earnings, because the equity yield becomes more attractive relative to cash and because the holdings' own borrowing costs fall. The rally from $27.32 to $35.30, a 29% gain, priced two to three cuts that never came. The 10-year went from 4.10% to 5.264% instead, and the Fed hiked.

The reversal was gradual and then sudden. SCHD held near its high through August as the market debated whether the September 16 meeting would be a hold or a hike. The hike came, the 10-year pushed through 5.0%, then 5.2%, then 5.264% on Monday, and the fund's six-week sideways drift became a five-day $3.44 billion outflow. The Fed's dot plot has 4.1% at end-2026 and end-2027 with 16 of 18 participants expecting at least one more hike this year, and money markets price nearly four hikes over twelve months. A dividend fund that rallied on cuts is now facing a hiking cycle, and the price has not yet adjusted to it.

The mechanical sensitivity is measurable. SCHD's holdings have a weighted-average beta near 0.75 and a duration-equivalent, the sensitivity of the price to the discount rate, that is closer to a 10-year bond than to the S&P 500. A 50-basis-point rise in the 10-year has historically produced a 5% to 7% decline in the fund over the following quarter, absent an offsetting earnings surprise. The 10-year has risen 115 basis points since January and the fund is up 20%, which means the rate sensitivity was overwhelmed by the rotation into defensives during the summer's AI-trade wobble. That rotation is what the five-day outflow is unwinding.

The week's data is the near-term driver. Wednesday's core PCE at a forecast 3.4% and Friday's payrolls at a forecast 84,000 decide whether the 10-year goes through 5.30% or backs toward 5.10%. A hot print takes the fund through $32.50 on the rate channel; a soft print gives it room to reclaim $33.50. The Fed's October 28 decision is the medium-term event. For SCHD the good outcome is the same as for every other rate-sensitive asset: a data miss that removes the October hike.

Flows: $38 Billion In Over a Year, $3.44 Billion Out in a Week, and What the Reversal Means

SCHD's asset-gathering run is the most successful in the dividend category's history and it is now showing its first crack. Over ten years the fund's net assets grew $105.07 billion. Over five years, $82.39 billion. Over three years, $61.15 billion. Over one year, $38.15 billion. Over six months, $10.72 billion. Over three months, $14.43 billion. Those numbers describe a fund that has taken in roughly $1 billion a week for a year on the strength of its 2026 performance and its status as the default dividend holding for retail and advisor portfolios. The five-day figure is negative $3.44 billion, and the one-month figure is negative $2.02 billion.

A $3.44 billion five-day outflow from a fund with net assets above $100 billion is a 3% redemption, which is not a run. But it is the first time since the March 2026 reconstitution that the fund has seen sustained net selling, and it coincides precisely with the 10-year breaking above 5.20%. The pattern in prior rate shocks, in 2022 when the 10-year went from 1.5% to 4.2%, is that dividend ETF flows lag the rate move by four to six weeks and then reverse for a quarter. On that timeline the outflow that began last week continues into November.

The context is a record year for U.S. ETF inflows overall, which hit $1.51 trillion before the fourth quarter. Money is not leaving ETFs; it is rotating within them. The destinations are duration, where a 10-year at 5.26% and a 30-year at 5.59% are the highest yields in eighteen years, and the covered-call complex, where JEPI at 7.88% and JEPQ at 13.40% pay more than double SCHD's 3.2% for investors who prioritize current income. The rotation out of SCHD is a rotation from growth-of-income to level-of-income, which is what a hiking cycle produces.

The counter-flow is the defensives bid in equities. Health care and consumer staples were two of only three S&P 500 sectors to close higher Monday, and Waters, Agilent and Biogen all hit new highs. SCHD's top holdings are exactly those sectors, and the fund's outperformance of the S&P 500 in September came from the AI-trade selloff rotating into the companies it owns. That equity rotation is fighting the rate rotation, and the price at $33.05 is the standoff between them. The flows say rates are winning this week.

The Peer Group: JEPI at 7.88%, JEPQ at 13.40%, VYM at 2.26%, VIG for Growth, and Where SCHD Sits

The dividend ETF market has four archetypes and SCHD is the balanced one. The Vanguard High Dividend Yield ETF VYM tracks the FTSE High Dividend Yield Index, holds 618 stocks weighted by market cap with a 0.74 beta and a 0.04% expense ratio, yields 2.19% to 2.26%, and manages $81 billion. It is the broad, low-drama diversifier, and it has lagged SCHD on total return over most windows because its market-cap weighting concentrates in financials and energy when those sectors yield most. The Vanguard Dividend Appreciation ETF VIG screens for 10 consecutive years of dividend increases rather than payments, yields roughly 2.3%, charges 0.06%, and is the fastest dividend grower; it holds the technology names SCHD cannot.

The JPMorgan Equity Premium Income ETF JEPI and its Nasdaq sibling JEPQ are the covered-call funds. JEPI yields 7.88% to 8.08%, JEPQ 13.40%, both at 0.35% expense ratios, both paying monthly, both generating the yield from option premium taxed as ordinary income. JEPI's trailing-twelve-month total return is 7.74% against SCHD's 26.24%, because the covered-call overlay capped its upside in a year when its holdings rallied. JEPQ's 19.94% total return and 21.62% three-year annualized return reflect its Nasdaq exposure. On a $10,000 investment, JEPI generates roughly $65.67 per monthly distribution, JEPQ $111.67, SCHD $80.50 per quarterly distribution, and VYM $56.50.

The comparison that matters in a 5.26% rate world is yield versus growth. JEPI pays 7.88% now and does not grow it; SCHD pays 3.2% now and grows it 7% to 11% a year. At a 5.26% risk-free rate, JEPI's yield is a 262-basis-point premium to Treasuries for taking equity risk with capped upside; SCHD's is a 206-basis-point discount to Treasuries for taking equity risk with uncapped upside and a rising payout. The market has decided, this quarter, that it prefers the premium. That is why JEPI and JEPQ have been taking the flows SCHD is losing.

SCHD's position in the group is the compounder. It is cheaper than the covered-call funds by 29 basis points, more selective than VYM by 518 holdings, higher-yielding than VIG by 90 basis points, and it has outperformed all of them on total return over twelve months. It is the fund to own for a decade. It is not the fund to own for the next six weeks of a Fed hiking cycle, and the flows reflect that distinction precisely.

The Holdings: Healthcare and Staples at the Top, Energy Cut in March, and a Portfolio Built for a Slowdown

SCHD's top holdings after the March reconstitution are Merck at 4.78%, Amgen at 4.72%, and Verizon, with the balance of the top ten weighted toward consumer staples, industrials and financials. The 4% position cap keeps any single name from dominating, and the 25% sector cap keeps the fund from concentrating in the highest-yielding sector, which in 2026 would have been energy. The index cut energy exposure at the March reconstitution despite crude above $90, because the four-factor screen penalized the sector's five-year dividend growth rate after the 2020 cuts and rewarded healthcare's balance-sheet metrics.

The healthcare tilt is working. Merck and Amgen are both up on the year with the pharmaceutical group catching a defensive bid through the September AI-trade selloff. Health care was one of three sectors to close higher Monday. The names SCHD added in March, high-yielding pharma and biotech with 10-year dividend records, are the ones that have led the fund's outperformance of the S&P 500 since the summer. Verizon at a 6%-plus yield is the telecom anchor, and it has held up as a bond proxy within the bond proxy.

The staples exposure is mixed. PepsiCo, a long-time constituent, fell this week on dual analyst downgrades over volume weakness and pricing pressure. Costco rose 2.7% on a fiscal fourth-quarter beat but is not a SCHD holding because its yield is too low for the screen. The staples names SCHD owns are the high-yield packaged-goods and beverage companies, and they are the part of the portfolio most exposed to the consumer squeeze from $4.15 gasoline and $6.50 diesel. Consumer confidence fell to 89.4 in August and the September consensus was only 90.1.

The industrials and financials sleeves are the cyclical exposure. Industrials rose 1% on the XLI Monday as the defensive bid extended to the sector, and SCHD's holdings there are the dividend-paying machinery and defense names that benefit from the reindustrialization theme. Financials fell Monday as the market worried about credit rather than net interest margin, and SCHD's bank and insurance holdings are the part of the portfolio most sensitive to the curve. The portfolio as a whole is built for a slowdown: high-quality, high-cash-flow, low-leverage companies that keep paying through a recession. That is the right portfolio for a Fed that is hiking into an energy shock. It is the wrong portfolio for a Treasury market that pays 5.26% for none of the risk.

Technicals: $32 Is the Line, $33.50 Is the Reclaim, $35.30 Is the High, $30 Is the Floor

The chart is a consolidation under a record high with a rising 200-day. Support first. $33.05 is Tuesday's print. $33.00 is the round number and the level the fund has oscillated around for six weeks. $32.50 is the low of the September range. $32.00 is the level that has held on every dip since June and the bottom of the six-week box; a daily close below it is the first confirmation that the outflows are becoming a trend. $31.50 is the 100-day moving average area. $30.81 is the April 1 high, which is now support. $30.44 is the April 1 low. $30.00 is the round number, where selling slowed on the last meaningful pullback, and roughly the 200-day moving average. $27.32 is where the fund started the year and the level a full retracement of the 2026 rally would reach.

Resistance next. $33.20 is Monday's NAV and the first level to reclaim. $33.50 is the 20-day moving average area and the top of the recent range. $34.00 is the round number and the 50-day moving average area, which has been resistance since the fund broke below it in early September. $34.50 is the mid-August consolidation. $35.00 is the round number below the high. $35.30 is the record high from the summer and the level that a return of the cut narrative would retest. $36.00 is the extension target on a break of the high.

The moving averages are stacked bullishly on the long term and flat on the short term. The fund is above its 200-day near $30 and its 100-day near $31.50, below its 50-day near $34 and its 20-day near $33.50. The 50-day is flattening after rising all year. Daily RSI is in the mid-40s, neutral. Volume on the recent down days has been above average, which is consistent with the $3.44 billion outflow.

The pattern is a six-week rectangle between $32 and $34 following a 29% rally, which is a distribution top if $32 breaks and a continuation base if $34 is reclaimed. A daily close below $32 targets $30.81 and then $30. A daily close above $34 targets $35.30. The bias is neutral with a bearish lean on the flows, and the level that decides it is $32.

The Bond-Proxy Framing: When Equity Income Yields Less Than Treasuries, the Growth Has to Carry the Price

SCHD is a bond proxy, and the analytical frame for a bond proxy in a hiking cycle is the spread between its yield and the risk-free rate. The fund yields 3.2%. The 10-year Treasury yields 5.264%. The spread is negative 206 basis points, the widest negative spread in the fund's history. For most of 2020 to 2022 the spread was positive, and the fund's price tracked rate expectations closely: it rallied when cuts were priced and fell when hikes were. The 2026 rally from $27.32 to $35.30 was the market pricing cuts that would have narrowed the negative spread; the September stall is the market pricing hikes that widen it.

The question is what closes the gap. There are three ways. The price can fall until the yield rises: at $30 the trailing yield is 3.5%, at $27 it is 3.9%, and at $25 it is 4.2%, which is roughly where the spread would be back at its 2024 average. The Treasury yield can fall: a 10-year at 4.50% narrows the spread to 130 basis points, which is where it was in the spring, and that requires the Fed to pause. Or the dividend can grow: at 7% to 11% a year, the $1.05 trailing payout becomes $1.13 to $1.17 next year, which at $33 is a 3.4% to 3.5% yield and narrows the spread by 20 to 30 basis points without any price move.

The market is choosing the first route this week. $3.44 billion of outflows in five days is the price falling to raise the yield. The bull case is that the third route, dividend growth, does enough of the work that the price does not have to fall far; a 7% payout increase over the next four quarters combined with a 10-year that stabilizes at 5.25% produces a spread of 175 basis points at $33, which the market tolerated in 2025. The bear case is that the second route goes the wrong way: a Fed that hikes in October and December takes the 10-year to 5.50%, the spread to 230 basis points, and the price to $30 to close it.

The comparison with a bond is the honest one. A 10-year Treasury bought at 5.264% returns 5.264% a year with no equity risk and full principal at maturity. SCHD bought at $33.05 returns 3.2% plus dividend growth of 7% to 11% plus or minus price change. Over ten years the SCHD position produces roughly $14 of cumulative dividends on a $33 investment against $17.40 of coupons on a $33 Treasury, and the equity position has to appreciate for the total return to match. It has, historically, by a wide margin. But the starting yield has never been this far below the bond, and the market is asking whether the growth premium is worth 206 basis points of foregone carry. This week the answer is no.

Bull Case: Defensives Keep Leading, the Fed Pauses, Dividend Growth Holds 7%, SCHD Retests $35.30

The bull case starts with the equity rotation. The S&P 500 erased its September gain Monday, the Nasdaq is flat with the AI trade cracking, and the only sectors working are health care, staples and industrials, which are SCHD's top three. The fund's trailing-twelve-month total return of 26.24% is the best in the dividend category by 6 points and it beat the S&P 500 for most of the year. The March reconstitution's pivot into healthcare and out of energy was the right call at the right time. The quality screen has done what it was built to do: own the companies that keep paying when the cycle turns.

The trigger is the Fed. A soft PCE Wednesday and a weak payrolls print Friday remove the October hike, take the 10-year toward 5.10%, and narrow the negative spread to 190 basis points. That is enough to stop the outflows, because the marginal seller is rotating on the rate differential and a 15-basis-point move in the 10-year is worth 3% on the fund. A Fed pause on October 28 takes the 10-year toward 4.90%, the spread to 170, and the fund back to $34. A Fed that signals the September hike was the last takes the fund to $35.30 by year-end as the cut narrative returns.

The structural case is the dividend. SCHD's payout has compounded at 11% a year for a decade and 7% over the past year. The December distribution, with an ex-date of December 9, is the next data point; a print above $0.28 would confirm the growth rate and put the trailing yield above 3.3% at $33. The fund's holdings are the companies with the strongest balance sheets and cash flows in the dividend universe, and they raise payouts through recessions. A 3.2% yield growing at 7% doubles the income in ten years; a 5.26% Treasury does not.

The path is a hold of $32, a reclaim of $33.50 on a soft U.S. print, $34 on a Fed pause, and $35.30 on a return of the cut narrative in the first quarter. The upside from $33.05 to $34 is 2.9%; to $35.30 it is 6.8%; plus the 3.2% yield. The bull case is a 10% total return over six months on a fund with a 0.75 beta, which is the best risk-adjusted outcome in the equity market if the Fed stops.

Bear Case: The Fed Hikes Twice More, the Spread Widens to 250 Basis Points, Outflows Compound, $30 Tests

The bear case starts with the flows. $3.44 billion in five days is the largest outflow in the fund's history, and it started the week the 10-year broke 5.20%. The 2022 template says dividend ETF outflows lag the rate move by a month and persist for a quarter. The fund is 6.4% below its high after a 29% rally, it is in a six-week rectangle that looks like distribution, and it is below its 20-day and 50-day moving averages for the first time since the spring. The AI-trade rotation into defensives that carried it through September is a one-time reallocation, not a recurring flow.

The trigger is a hot PCE and a strong payrolls. Core PCE at 3.5% or above and payrolls above 130,000 confirm the October hike, push the 10-year through 5.30%, and take October hike odds toward 85%. The negative spread goes to 220 basis points and the fund loses $32 on the rate channel alone. A Fed that hikes on October 28 and signals December takes the 10-year to 5.50%, the spread to 250, and the fund to $30.81, the April high, and then $30, the 200-day. That is a 9% decline from Tuesday's price, and it is where the trailing yield reaches 3.5%.

The structural risk is the holdings. SCHD's consumer staples sleeve is exposed to a consumer squeezed by $4.15 gasoline, $6.50 diesel and a Fed hiking into it; PepsiCo's dual downgrades this week are the first crack. The financials sleeve is exposed to a credit cycle that the market started pricing Monday when banks fell on a day rates rose. The healthcare sleeve has carried the fund but is now crowded after a month of defensive rotation. And the fund has no technology, which means it does not participate if the AI trade recovers and the Nasdaq reclaims 27,500.

The tail is a Fed that hikes three times and a 10-year at 5.75%. That takes the spread to 275 basis points, the widest in history for any dividend fund, and the price to $27.32, the start-of-year level, a 17% decline. The bear case is a 30% probability, and it depends entirely on the bond market. The fund's business quality does not change; its relative attractiveness against a risk-free asset that pays 5.26% does.

What to Watch: PCE, Payrolls, the Weekly Flow Print, the December Distribution, and $32

The macro calendar drives the fund this week. Wednesday's core PCE at a forecast 3.4% year over year is the first print that can move the 10-year 10 basis points; Friday's payrolls at a forecast 84,000, with jobless claims trending lower, is the second. The Fed's October 28 decision at 70% odds is the medium-term event. Any Fed speaker walking back October is worth 2% on SCHD; any reinforcing it is worth the same in reverse. Consumer confidence and JOLTS landed Tuesday and set the tone for the consumer-staples sleeve.

The fund-specific calendar is the weekly flow print, which will show whether the $3.44 billion five-day outflow was a one-week rotation or the start of a quarter-long reversal. A second week of $2 billion-plus outflows confirms the 2022 pattern. A return to inflows on a soft U.S. print confirms the rotation was rate-driven and reversible. The fourth-quarter rebalance of the underlying index, typically in December, is the next portfolio event; it will adjust weights but not constituents. The December distribution, ex-date December 9, is the next dividend data point.

The cross-asset watch is the 10-year Treasury against 5.30% above and 5.10% below, the health care and staples sectors' relative performance against the S&P 500, and JEPI's flows as the indicator of whether income money is rotating within equities or out of them. The S&P 500 at 7,681 and the Nasdaq at 26,826 are the read on whether the defensive bid persists; a Nasdaq rally to 27,500 on an AI recovery would pull money out of SCHD's sectors and into technology.

The technical triggers are $32 below and $34 above. A daily close below $32 confirms the distribution top and targets $30.81 and $30. A daily close above $34 reclaims the 50-day and targets $35.30. The six-week rectangle has compressed volatility, and the break will be fast.

Verdict: Hold Above $32, Trim Into $34, Buy at $30 With a 3.5% Yield, and Let the Dividend Growth Do the Work

SCHD at $33.05 is a hold for income investors who own it, a trim into $34 for anyone who bought the 2026 rally, and a buy at $30 for anyone building a position. The fund is the best-constructed dividend ETF in the market: 100 companies with 10-year dividend records screened on cash flow to debt, return on equity, yield and growth, weighted with a 4% cap and a 25% sector cap, rebalanced quarterly, reconstituted annually, at a 0.06% expense ratio. It returned 26.24% over the past twelve months against 7.74% for JEPI and 14.37% for VYM. It pays $1.05 a year, up 7% year over year and 11% annualized over a decade, in qualified dividends. Its healthcare, staples and industrials holdings are the only sectors working in a market where the AI trade is cracking.

The fund also yields 3.2% against a 10-year Treasury at 5.264%, a negative spread of 206 basis points that is the widest in its history, and it has lost $3.44 billion of assets in five days as income allocators rotate into duration and covered-call funds. Its 2026 rally from $27.32 to $35.30 priced Fed cuts that turned into a Fed hike, and the six-week stall since is the market repricing that. It sits below its 20-day and 50-day moving averages in a rectangle that resolves down if $32 breaks. And the week's macro data, with claims trending lower into an 84,000 payrolls consensus, leans toward the dollar and the hike.

The forecast: SCHD holds $32 through Wednesday's PCE and trades a $32 to $33.50 range into Friday's payrolls, with the direction of the break decided by the 10-year. A soft print stops the outflows, reclaims $33.50, and targets $34 into the October 28 Fed, with $35.30 the retest if the Fed pauses. A hot print breaks $32, extends the outflows for a second week, and targets $30.81 and $30 by mid-October, where the trailing yield reaches 3.5% and the negative spread narrows to 175 basis points. The odds tilt modestly bearish into the data on the flow pattern, and modestly bullish over six months on the dividend growth and the defensive rotation.

The trade is to hold above $32 with the understanding that the price is a function of the bond market for the next month, to trim 20% into $34 if the fund gets there on a soft print, and to add at $30 with a 3.5% yield and a 200-day moving average underneath. SCHD is a decade holding that is having a bad quarter, and the bad quarter is the Fed's, not the fund's. When the hiking cycle ends, the 3.2% yield that grows 7% a year will look cheap again against a Treasury that does not grow at all. Until it ends, the Treasury wins the carry, and the price has to reflect that.

That's TradingNEWS